Approval · Notice of Compliance 2732 · 2003
AMATINE: Notice of Compliance 2732
Issued July 21, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2732
- Date
- July 21, 2003
- Company
- Shire Biochem Inc.Saint Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Vasopressor
Products in this notice
Medicinal ingredients
- MIDODRINE HCL 2.5 MG per TAB
- MIDODRINE HCL 5 MG per TAB
- MIDODRINE HCL 10 MG per TAB